Grufity logo
Grufity logo
LQDA

LQDA - Liquidia Corporation Stock Price, Fair Value and News

$67.85-1.27 (-1.84%)
Market Closed as of 10 Sep 2026, 04:00 pm ET

LQDA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LQDA Price Action

Last 7 days

-1.1%

Last 30 days

-22.9%

Last 90 days

-4.7%

Trailing 12 Months

148.6%

LQDA RSI Chart

LQDA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LQDA Valuation

Market Cap

6.1B

Price/Earnings (Trailing)

43.81

Price/Sales (Trailing)

13.47

EV/EBITDA

66.75

Price/Free Cashflow

40.3

LQDA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LQDA Fundamentals

LQDA Revenue

Revenue (TTM)

450.9M

Rev. Growth (Yr)

1.8K%

Rev. Growth (Qtr)

29.21%

LQDA Earnings

Earnings (TTM)

138.6M

Earnings Growth (Yr)

279.71%

Earnings Growth (Qtr)

41.35%

LQDA Profitability

EBT Margin

12.98%

Return on Equity

71.04%

Return on Assets

26.56%

Free Cashflow Yield

2.48%

LQDA Investor Care

Shares Dilution (1Y)

4.25%

Diluted EPS (TTM)

1.4

LQDA Alerts

  • 3 major insider sales recently.
  • Big jump in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)
Revenue & Growth

How Liquidia Corporation generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2026288.1M450.9M--
202514.1M19.3M69.2M158.3M
202416.0M14.8M15.6M14.0M
202316.9M17.8M18.3M17.5M
202213.3M13.8M13.8M15.9M
20213.8M6.8M9.8M12.9M
2020---739.6K
2019---8.1M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Liquidia Corporation

LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
 CEO
 WEBSITEliquidia.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES63

Liquidia Corporation Frequently Asked Questions

LQDA is the stock ticker symbol of Liquidia Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Sep 10 2026, market cap of Liquidia Corporation is 6.07 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu Sep 10 2026, LQDA's PE ratio (Price to Earnings) is 43.81 and Price to Sales (PS) ratio is 13.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LQDA PE ratio will change depending on the future growth rate expectations of investors.